Effects of nutrient and bioactive food components on Alzheimer's disease and epigenetic

被引:16
|
作者
Celik, Elif [1 ]
Sanlier, Nevin [1 ]
机构
[1] Gazi Univ, Fac Hlth Sci, Nutr & Dietet Dept, Ankara, Turkey
关键词
Alzheimer; nutrition; nutritional components; epigenetics; D-RECEPTOR GENE; INDUCED MICROGLIAL ACTIVATION; STEM-CELL PROLIFERATION; TUMOR-SUPPRESSOR GENES; VITAMIN-K ANTAGONISTS; AMYLOID-BETA; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; OLEUROPEIN AGLYCONE; GLUCOSE-METABOLISM;
D O I
10.1080/10408398.2017.1359488
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Alzheimer's disease (AD) is the most common form of dementia in the elderly and is a chronic neurodegenerative disease that is becoming widespread. For this reason, in recent years factors affecting the development, progression and cognitive function of the AD have been emphasized. Nutrients and other bioactive nutrients are among the factors that are effective in AD. In particular, vitamins A, C and E, vitamins B-1, B-6 and B-12, folate, magnesium, choline, inositol, anthocyanins, isoflavones etc. nutrients and bioactive nutrients are known to be effective in the development of AD. Nutrients and nutrient components may also have an epigenetic effect on AD. At the same time, nutrients and bioactive food components slow down the progression of the disease. For this reason, the effect of nutrients and food components on AD was examined in this review.
引用
收藏
页码:102 / 113
页数:12
相关论文
共 50 条
  • [31] Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease
    Khavinson, Vladimir
    Ilina, Anastasiia
    Kraskovskaya, Nina
    Linkova, Natalia
    Kolchina, Nina
    Mironova, Ekaterina
    Erofeev, Alexander
    Petukhov, Michael
    PHARMACEUTICALS, 2021, 14 (06)
  • [32] Epigenetic regulation of cognitive decline in Alzheimer's disease
    Graff, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S26 - S26
  • [33] Epigenetic drugs for Alzheimer's disease: hopes and challenges
    Caraci, Filippo
    Leggio, Gian Marco
    Drago, Filippo
    Salomone, Salvatore
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (04) : 1154 - 1155
  • [34] Epigenetic modifications of DNA and RNA in Alzheimer's disease
    Martinez-Feduchi, Paula
    Jin, Peng
    Yao, Bing
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2024, 17
  • [35] Epigenetic Inhibitors as Alzheimer's Disease Therapeutic Agents
    Yamashita, Yasunobu
    Itoh, Yukihiro
    Takada, Yuri
    Suzuki, Takayoshi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (07) : 630 - 637
  • [36] Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
    Yu, Chao-Chao
    Jiang, Tao
    Yang, Ao-Fei
    Du, Yan-Jun
    Wu, Miao
    Kong, Li-Hong
    NEURAL PLASTICITY, 2019, 2019
  • [37] An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation
    Feng, Boyi
    Zheng, Junli
    Cai, Ying
    Han, Yaguang
    Han, Yanhua
    Wu, Jiaqi
    Feng, Jun
    Zheng, Kai
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2024, 52 (03): : 365 - 374
  • [38] Potential Epigenetic Targets for Combating Alzheimer's Disease
    Pandey, Dheeraj
    Pal, Tiyas
    Sharma, Abha
    Flora, S. J. S.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2021, 21 (12) : 1527 - 1540
  • [39] Epigenetic dysregulation in Alzheimer's disease peripheral immunity
    Ramakrishnan, Abhirami
    Piehl, Natalie
    Simonton, Brooke
    Parikh, Milan
    Zhang, Ziyang
    Teregulova, Victoria
    van Olst, Lynn
    Gate, David
    NEURON, 2024, 112 (08) : 1235 - 1248.e5
  • [40] Epigenetic Epidemiology: Examples from Alzheimer's Disease
    Rozek, L. S.
    Dolinoy, D. C.
    Bakulski, K.
    Sartor, M. A.
    Hu, H.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2011, 52 : S21 - S21